209 related articles for article (PubMed ID: 26916836)
21. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients.
Del Bello A; Congy-Jolivet N; Muscari F; Lavayssière L; Esposito L; Cardeau-Desangles I; Guitard J; Dörr G; Suc B; Duffas JP; Alric L; Bureau C; Danjoux M; Guilbeau-Frugier C; Blancher A; Rostaing L; Kamar N
Am J Transplant; 2014 Apr; 14(4):867-75. PubMed ID: 24580771
[TBL] [Abstract][Full Text] [Related]
23. Antibody-mediated rejection in pediatric liver transplant recipients.
Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
[TBL] [Abstract][Full Text] [Related]
24. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
Yell M; Muth BL; Kaufman DB; Djamali A; Ellis TM
Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
[TBL] [Abstract][Full Text] [Related]
25. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection.
Jackups R; Canter C; Sweet SC; Mohanakumar T; Morris GP
J Clin Apher; 2013 Aug; 28(4):301-8. PubMed ID: 23426730
[TBL] [Abstract][Full Text] [Related]
26. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
[TBL] [Abstract][Full Text] [Related]
27. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
28.
Beyzaei Z; Geramizadeh B; Bagheri Z; Karimzadeh S; Shojazadeh A
Front Immunol; 2020; 11():613128. PubMed ID: 33424868
[TBL] [Abstract][Full Text] [Related]
29. Antibody-mediated rejection: what is the clinical relevance?
Hogen R; DiNorcia J; Dhanireddy K
Curr Opin Organ Transplant; 2017 Apr; 22(2):97-104. PubMed ID: 28060025
[TBL] [Abstract][Full Text] [Related]
30. The role of donor-specific HLA alloantibodies in liver transplantation.
O'Leary JG; Demetris AJ; Friedman LS; Gebel HM; Halloran PF; Kirk AD; Knechtle SJ; McDiarmid SV; Shaked A; Terasaki PI; Tinckam KJ; Tomlanovich SJ; Wood KJ; Woodle ES; Zachary AA; Klintmalm GB
Am J Transplant; 2014 Apr; 14(4):779-87. PubMed ID: 24580828
[TBL] [Abstract][Full Text] [Related]
31. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
Bouquegneau A; Loheac C; Aubert O; Bouatou Y; Viglietti D; Empana JP; Ulloa C; Murad MH; Legendre C; Glotz D; Jackson AM; Zeevi A; Schaub S; Taupin JL; Reed EF; Friedewald JJ; Tyan DB; Süsal C; Shapiro R; Woodle ES; Hidalgo LG; O'Leary J; Montgomery RA; Kobashigawa J; Jouven X; Jabre P; Lefaucheur C; Loupy A
PLoS Med; 2018 May; 15(5):e1002572. PubMed ID: 29799874
[TBL] [Abstract][Full Text] [Related]
32. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
33. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ
Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
[TBL] [Abstract][Full Text] [Related]
35. Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation.
Kim H; Yi NJ; Song EY; Lee K; Lee KW; Lee HW; Ahn HY; Yoon KC; Hong SK; Suh KS
Clin Transplant; 2018 May; 32(5):e13244. PubMed ID: 29577436
[TBL] [Abstract][Full Text] [Related]
36. Humoral immunity and antibody-mediated rejection in solid organ transplantation.
Montgomery RA; Cozzi E; West LJ; Warren DS
Semin Immunol; 2011 Aug; 23(4):224-34. PubMed ID: 21958960
[TBL] [Abstract][Full Text] [Related]
37. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
38. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
[TBL] [Abstract][Full Text] [Related]
39. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
[TBL] [Abstract][Full Text] [Related]
40. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
Lúcia M; Luque S; Crespo E; Melilli E; Cruzado JM; Martorell J; Jarque M; Gil-Vernet S; Manonelles A; Grinyó JM; Bestard O
Kidney Int; 2015 Oct; 88(4):874-87. PubMed ID: 26176829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]